Table 1. Characteristics of A. baumannii Clinical Isolates Included in This Study.
| Isolate* | Antimicrobial susceptibilities (inhibition zone diameter, mm) | MIC (mg/mL) | MLST | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| CAZ | CTX | FEP | AN | GM | CIP | CL | MEM | IPM | ST | |
| AB001 | R (9) | R (9) | R (10) | S (24) | S (18) | R (9) | 0.25 | 256 | 64 | 138 |
| AB002 | R (9) | R (9) | R (10) | S (23) | S (17) | R (9) | 0.25 | 256 | 64 | 138 |
| AB003 | R (9) | R (9) | R (11) | R (9) | R (9) | R (9) | 16 | 256 | 64 | 138 |
AN, amikacin; CAZ, ceftazidime; CIP, ciprofloxacin; CL, colistin; CTX, cefotaxime; FEP, cefepime; GM, gentamicin; IPM, imipenem; MEM, meropenem; MLST, multi-locus sequence typing; R, resistance; S, susceptible; ST, sequence type.
*AB001 and AB002 are colistin-susceptible isolates and AB003 is the colistin-resistant counterpart.